Other in vitro studies have indicated that increased irisin levels could lead to the inhibition of proliferation, migration, and the epithelial–mesenchymal transition (EMT) through the PI3K/AKT pathway in lung cancer cells [15]. The gene discussed is FNDC5; the disease is lung cancer.